Turning Point Brands (NYSE: TPB) reported Q1 EPS of $0.76, $0.17 better than the analyst estimate of $0.59. Revenue for the quarter came in at $124.3 million versus the consensus estimate of $123.76 million.

2026 Outlook

Full year Modern Oral Gross Sales of $280-$300 million (from $220- $240 million)
Full year Modern Oral Net Sales of $210-$225 million (from $180- $190 million)
Full Year Adjusted EBITDA of $70-$90 million, inclusive of investment in Modern Oral sales, marketing, and trade promotions

For earnings history and earnings-related data on Turning Point Brands (TPB) click here.